Sale!

PKP2 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 9 Genetic Test Cost

Name: PKP2 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 9 Genetic Test Cost
SKU: TEST-3317
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PKP2 gene arrhythmogenic right ventricular cardiomyopathy type 9 genetic test is a specialized diagnostic tool designed to identify mutations in the PKP2 gene, which are linked to arrhythmogenic right ventricular cardiomyopathy (ARVC) type 9. ARVC is a form of heart disease that affects the muscle of the right ventricle, leading to arrhythmias and heart failure. The condition is genetic and can be passed down through families.

This specific test is crucial for individuals with a family history of ARVC or those showing symptoms of the condition, such as palpitations, fainting, or sudden cardiac arrest, as early detection can significantly influence management and treatment strategies. By analyzing the PKP2 gene, healthcare providers can confirm the diagnosis of ARVC type 9, assess the risk of developing the condition among family members, and implement preventative measures or treatments to mitigate heart damage and improve patient outcomes.

The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive information it provides to both patients and healthcare professionals. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, which is critical for managing a condition as serious as ARVC type 9.

Description

PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 Genetic Test

Components: PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 NGS Genetic DNA Test gene PKP2

Test Details: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder that affects the heart muscle and can lead to abnormal heart rhythms and potentially life-threatening arrhythmias. It is characterized by the replacement of the normal heart muscle tissue with fibrous and fatty tissue. The PKP2 gene (Plakophilin-2 gene) is one of the genes associated with ARVC. Mutations in the PKP2 gene can disrupt the normal structure and function of the heart muscle cells, leading to the development of ARVC. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to rapidly analyze multiple genes simultaneously. In the case of ARVC, NGS genetic testing can be used to identify mutations in the PKP2 gene and other genes associated with the condition. By analyzing the patient’s DNA sample, NGS genetic testing can provide valuable information about the presence of PKP2 gene mutations and help in the diagnosis and management of ARVC. It can also be used for genetic counseling and to identify at-risk family members who may carry the same mutation. It is important to note that ARVC is a complex genetic disorder, and mutations in other genes, such as desmosomal genes (e.g., DSP, DSG2, and DSC2), can also cause the condition. Therefore, a comprehensive genetic testing panel that includes multiple genes associated with ARVC is typically recommended for accurate diagnosis and risk assessment.

Test Name	PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PKP2 Gene Arrhythmogenic right ventricular cardiomyopathy type 9 NGS Genetic DNA Test gene PKP2
Test Details	Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder that affects the heart muscle and can lead to abnormal heart rhythms and potentially life-threatening arrhythmias. It is characterized by the replacement of the normal heart muscle tissue with fibrous and fatty tissue. The PKP2 gene (Plakophilin-2 gene) is one of the genes associated with ARVC. Mutations in the PKP2 gene can disrupt the normal structure and function of the heart muscle cells, leading to the development of ARVC. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to rapidly analyze multiple genes simultaneously. In the case of ARVC, NGS genetic testing can be used to identify mutations in the PKP2 gene and other genes associated with the condition. By analyzing the patient’s DNA sample, NGS genetic testing can provide valuable information about the presence of PKP2 gene mutations and help in the diagnosis and management of ARVC. It can also be used for genetic counseling and to identify at-risk family members who may carry the same mutation. It is important to note that ARVC is a complex genetic disorder, and mutations in other genes, such as desmosomal genes (e.g., DSP, DSG2, and DSC2), can also cause the condition. Therefore, a comprehensive genetic testing panel that includes multiple genes associated with ARVC is typically recommended for accurate diagnosis and risk assessment.